Cocrystal Other Liab vs Other Current Liab Analysis
COCP Stock | USD 1.56 0.05 3.31% |
Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Other Liab and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.
Other Liab vs Other Current Liab
Other Liab vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cocrystal Pharma Other Liab account and Other Current Liab. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cocrystal Pharma's Other Liab and Other Current Liab is -0.19. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Other Liab and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Cocrystal Pharma are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Other Liab i.e., Cocrystal Pharma's Other Liab and Other Current Liab go up and down completely randomly.
Correlation Coefficient | -0.19 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Other Liab
Other Current Liab
Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 04/28/2024, Enterprise Value Multiple is likely to grow to 0.37, while Selling General Administrative is likely to drop 5,690.
2023 | 2024 (projected) | Non Recurring | 41.5M | 36.9M | Reconciled Depreciation | 412K | 302.2K |
Cocrystal Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Cocrystal Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cocrystal Pharma fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 28.5M | 54.2M | 79.4M | 40.8M | 31.3M | 29.7M | |
Total Current Liabilities | 2.3M | 1.4M | 1.5M | 1.2M | 3.3M | 2.7M | |
Total Stockholder Equity | 25.7M | 52.5M | 77.5M | 39.6M | 26.4M | 42.6M | |
Net Debt | (6.6M) | (32.4M) | (58.2M) | (36.8M) | (24.6M) | (23.3M) | |
Retained Earnings | (235.3M) | (244.9M) | (259.1M) | (297.9M) | (315.9M) | (300.1M) | |
Accounts Payable | 1.5M | 657K | 578K | 614K | 1.2M | 931.8K | |
Cash | 7.4M | 33.0M | 58.7M | 37.1M | 26.4M | 27.7M | |
Non Current Assets Total | 20.3M | 20.2M | 20.1M | 662K | 2.2M | 2.1M | |
Non Currrent Assets Other | (293K) | 40K | 50K | 46K | 46.0K | 48.3K | |
Cash And Short Term Investments | 7.4M | 33.0M | 58.7M | 37.1M | 26.4M | 27.7M | |
Common Stock Total Equity | 24K | 30K | 36K | 71K | 81.7K | 152.4K | |
Common Stock Shares Outstanding | 31.9M | 55.2M | 88.4M | 8.1M | 9.7M | 13.1M | |
Liabilities And Stockholders Equity | 28.5M | 54.2M | 79.4M | 40.8M | 31.3M | 29.7M | |
Other Stockholder Equity | 260.9M | 297.3M | 336.5M | 337.5M | 342.3M | 359.4M | |
Total Liab | 2.8M | 1.7M | 1.8M | 1.3M | 4.9M | 4.6M | |
Total Current Assets | 8.3M | 34.0M | 59.3M | 40.2M | 29.1M | 30.5M | |
Common Stock | 36K | 71K | 98K | 8K | 10K | 9.5K | |
Other Current Liab | 7K | 61K | 12K | 362K | 1.8M | 1.7M | |
Property Plant And Equipment Net | 1.1M | 1.1M | 931K | 616K | 2.1M | 2.2M | |
Other Current Assets | 169K | 399K | 568K | 2.2M | 1.8M | 930.3K | |
Property Plant And Equipment Gross | 1.1M | 1.1M | 2.4M | 2.2M | 3.9M | 4.1M | |
Short Long Term Debt Total | 817K | 596K | 534K | 297K | 1.9M | 1.6M | |
Non Current Liabilities Total | 537K | 379K | 298K | 57K | 1.6M | 1.5M | |
Short Term Debt | 280K | 217K | 236K | 240K | 216K | 205.2K | |
Net Tangible Assets | 6.6M | 33.4M | 58.5M | 39.6M | 35.6M | 34.6M | |
Other Assets | 50K | 544K | 46K | 0.0 | 1.0 | 0.95 | |
Retained Earnings Total Equity | (138.0M) | (187.1M) | (235.3M) | (244.9M) | (220.4M) | (209.4M) | |
Capital Surpluse | 243.4M | 253.9M | 260.9M | 297.3M | 341.9M | 215.9M | |
Property Plant Equipment | 1.1M | 1.1M | 931K | 616K | 708.4K | 640.6K | |
Net Invested Capital | 25.7M | 52.5M | 77.5M | 39.6M | 26.4M | 45.1M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cocrystal Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cocrystal Pharma's short interest history, or implied volatility extrapolated from Cocrystal Pharma options trading.
Pair Trading with Cocrystal Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Cocrystal Stock
0.62 | CICHF | China Construction Bank | PairCorr |
0.54 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
0.44 | PBCRF | PT Bank Central | PairCorr |
0.41 | TRV | The Travelers Companies Financial Report 18th of July 2024 | PairCorr |
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.Note that the Cocrystal Pharma information on this page should be used as a complementary analysis to other Cocrystal Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Cocrystal Stock analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Cocrystal Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.87) | Revenue Per Share 0.006 | Quarterly Revenue Growth 0.269 | Return On Assets (0.37) | Return On Equity (0.55) |
The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.